U.S. Digital Therapeutics Market, By Application ((Treatment & Disease Management (Chronic Care, Mental Health & Neurological Disorders, and Others) and Preventive Care (Pre-diabetes, Weight Management, and Others)) and By End User (Healthcare Providers, Patients/Individuals, Payers, Employers, and Others)-

Published In : May 2023

Code : CMI5690

Pages :157

Formats :

Excel and PDF

Industry : Healthcare IT

Market Challenges And Opportunities

U.S. Digital Therapeutics Market Drivers:

High prevalence of chronic diseases to drive market growth

One of the key factors expected to augment the growth of the U.S. Digital Therapeutics Market over the forecast period is the increase in incidence of chronic diseases in the U.S. For instance, chronic diseases are highly...

The outbreak of COVID-19 to propel market growth...

Another factor which is driving the growth of the U.S. Digital Therapeutics Market is the outbreak of COVID-19 (pandemic). For instance, as a result of the pandemic, the adoption of digital health is...

Restraints:

Growing concerns about data privacy to hinder market growth...

One of the key factors expected to hamper the growth of the U.S. Digital Therapeutics Market is the growing concerns about patient data privacy. Security/privacy risks are one of the major challenges for the market as the nature of data, and is vulnerable to ...

Challenges involved with DTx to hamper market growth...

Another factor which is hampering growth of the U.S. Digital Therapeutics Market is the economical and technical challenges involved with DTx. Some of the major challenges involved with digital therapeutics include less reimbursement, lower physician adoption, lack of awareness and training, compatibility issues, and others...